StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
AGM/EGMJun 24, 2026, 04:57 PM

Scilex Stockholders Approve Director, Auditor, Equity Plan

AI Summary

Scilex Holding Company held its 2026 Annual Meeting of Stockholders on June 24, 2026. Stockholders voted on three proposals, all of which passed. These included the election of Dorman Followwill as a Class I director, the ratification of BPM LLP as the company's independent auditor for fiscal year 2026, and the approval of an amendment to the 2022 Equity Incentive Plan to increase authorized shares by 1,300,000.

Key Highlights

  • Dorman Followwill was elected as a Class I director with 3,945,473 votes For.
  • BPM LLP was ratified as the independent registered public accounting firm for 2026 with 5,956,622 votes For.
  • Amendment to the 2022 Equity Incentive Plan was approved with 3,337,435 votes For.
  • The Equity Incentive Plan amendment increases authorized shares by 1,300,000 to 2,765,789 shares.
  • 100% of Series A preferred stock and approximately 63.5% of common stock were represented at the meeting.